Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequ
ClinicalTrials.gov study NCT01500278. IPD Sharing: Not stated. Countries: 20. Publications: 3.
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05073315. IPD Sharing: YES. Countries: 6. Publications: 0.
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
ClinicalTrials.gov study NCT02128490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheu
ClinicalTrials.gov study NCT00891020. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT01093469. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02850965. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/
ClinicalTrials.gov study NCT03970837. IPD Sharing: YES. Countries: 18. Publications: 1.
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02435992. IPD Sharing: Not stated. Countries: 30. Publications: 6.
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT01548404. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00115076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03392168. IPD Sharing: NO. Countries: 2. Publications: 2.
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
ClinicalTrials.gov study NCT02299297. IPD Sharing: YES. Countries: 1. Publications: 1.
Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.
ClinicalTrials.gov study NCT03108482. IPD Sharing: NO. Countries: 1. Publications: 2.
CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
ClinicalTrials.gov study NCT03636269. IPD Sharing: NO. Countries: 11. Publications: 5.
A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016)
ClinicalTrials.gov study NCT05386589. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT01437540. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
ClinicalTrials.gov study NCT04343651. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00479557. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00677807. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD
ClinicalTrials.gov study NCT01985334. IPD Sharing: Not stated. Countries: 23. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.